Colon Screening Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2025-2032

Description

Persistence Market Research has recently released a comprehensive report on the colon screening market. The report offers a thorough assessment of crucial market dynamics, including drivers, trends, opportunities, and challenges, providing detailed insights into the market structure. This research publication presents exclusive data and statistics outlining the anticipated growth trajectory of the global colon screening market from 2025 to 2032.

Key Insights:

Colon Screening Market Size (2025E): USD 18.7 Billion
Projected Market Value (2032F): USD 24.45 Billion
Global Market Growth Rate (CAGR 2025 to 2032): 3.9%

Colon Screening Market - Report Scope:

Colon screening involves diagnostic methods used for early detection of colorectal abnormalities and colorectal cancer (CRC), which is among the most common and fatal cancers worldwide. Major screening techniques include stool-based tests such as fecal immunochemical tests (FIT) and fecal occult blood tests (FOBT), colonoscopy, flexible sigmoidoscopy, capsule endoscopy, and others. The market covers screening products such as endoscopes, CT scanners, capsule endoscopes, and test kits & reagents, catering to hospitals, diagnostic & imaging centers, and other healthcare facilities. Growth is driven by rising CRC incidence, increasing awareness and preventive initiatives, and advancements in diagnostic technologies.

Market Growth Drivers:

The global colon screening market is primarily driven by the growing incidence of colorectal cancer, prompting expansion of national screening programs and early detection efforts. CRC was the third most common cancer globally in 2020, with an estimated 1.9 million new cases that year, and projections indicate cases may exceed 3.2 million annually by 2040. Alliances between governments, healthcare systems, and public health agencies aim to increase screening participation, reducing mortality and long-term treatment costs. Growing investments in non-invasive screening technologies, telemedicine integration, and AI-assisted endoscopic diagnostics further bolster market growth.

Market Restraints:

Despite the market's growth prospects, certain challenges exist. Sensitivity limitations of some screening methods, especially non-invasive tests such as FIT and FOBT, can lead to false negatives, particularly for advanced adenomas, necessitating follow-up colonoscopy tests. Such limitations may affect healthcare professionals' screening choices or result in delayed diagnosis. Regulatory complexities and variations in reimbursement policies across regions may also impact adoption rates among different population segments.

Market Opportunities:

Significant opportunities lie in expanding access to telemedicine and at-home testing tools, making early screening more convenient and accessible. Non-invasive stool DNA and RNA-based tests, including emerging products like Colosense and enhanced ColoAlert, expand screening reach, particularly among individuals reluctant to undergo invasive procedures. Healthcare initiatives distributing free screening kits and integrating AI into diagnostics are expected to enhance market penetration and patient compliance.

Key Questions Answered in the Report:

What are the primary factors driving the growth of the colon screening market globally?
Which screening types and products are most widely adopted across healthcare systems?
How are technological advancements reshaping the competitive landscape of the colon screening market?
Who are the key players in the global colon screening market, and what strategies are they employing to maintain market relevance?
What are the emerging trends and future prospects in the global colon screening market?

Competitive Intelligence and Business Strategy:

Leading players in the colon screening market focus on enhancing diagnostic accuracy, expanding product offerings, and forging strategic collaborations to strengthen market presence. Companies leverage advanced imaging tools, AI-enabled endoscopy platforms, and telehealth solutions to improve early detection rates and patient outcomes. Partnerships with healthcare providers, government screening initiatives, and technology developers facilitate broader adoption of innovative screening solutions. Continuous R&D investments and new product launches are essential for sustaining competitive advantage.

Key Companies Profiled:

Olympus Corporation
PENTAX Medical (Hoya Corporation)
FUJIFILM Holdings Corporation
Medtronic
Ambu A/S
Baxter (Hillrom & Welch Allyn)
EndoFresh
Bracco
Varay Laborix
Guardant Health, Inc.
Novigenix SA
Eiken Chemical Co., Ltd.
Mainz Biomed N.V.

Colon Screening Market Research Segmentation:

By Screening Type

Stool-Based Tests
Fecal Immunochemical Test (FIT)
Guaiac-Based Fecal Occult Blood Test (gFOBT)
Colonoscopy
Flexible Sigmoidoscopy
Capsule Endoscopy
Others

By Product Type

Endoscopes
CT Scanners
Capsule Endoscopes
Test Kits & Reagents
Others

By End-user

Hospitals
Diagnostic & Imaging Centers
Research & Academic Institutions
Others

By Region

North America
Europe
East Asia
South Asia and Oceania
Middle East and Africa
Latin America

Product Code: PMRREP35162

1. Executive Summary

1.1. Global Colon Screening Market Snapshot, 2025 and 2032
1.2. Market Opportunity Assessment, 2025-2032, US$ Bn
1.3. Key Market Trends
1.4. Future Market Projections
1.5. Premium Market Insights
1.6. Industry Developments and Key Market Events
1.7. PMR Analysis and Recommendations

2. Market Overview

2.1. Market Scope and Definition
2.2. Market Dynamics
- 2.2.1. Drivers
- 2.2.2. Restraints
- 2.2.3. Opportunity
- 2.2.4. Key Trends
2.3. Macro-economic Factors
- 2.3.1. Global Sectoral Outlook
- 2.3.2. Global GDP Growth Outlook
2.4. COVID-19 Impact Analysis
2.5. Forecast Factors - Relevance and Impact

3. Value Added Insights

3.1. Tool Adoption Analysis
3.2. Regulatory Landscape
3.3. Value Chain Analysis
3.4. PESTLE Analysis
3.5. Porter's Five Force Analysis

4. Price Analysis, 2024A

4.1. Key Highlights
4.2. Key Factors Impacting Deployment Costs
4.3. Pricing Analysis, By Product Type

5. Global Colon Screening Market Outlook

5.1. Key Highlights
- 5.1.1. Market Volume (Units) Projections
- 5.1.2. Market Size (US$ Bn) and Y-o-Y Growth
- 5.1.3. Absolute $ Opportunity
5.2. Market Size (US$ Bn) and Volume (Units) Analysis and Forecast
- 5.2.1. Historical Market Size (US$ Bn) Analysis, 2019-2024
- 5.2.2. Current Market Size (US$ Bn) Analysis and Forecast, 2025-2032
5.3. Global Colon Screening Market Outlook: Screening Type
- 5.3.1. Introduction / Key Findings
- 5.3.2. Historical Market Size (US$ Bn) and Volume (Units) Analysis, By Screening Type, 2019 - 2024
- 5.3.3. Current Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By Screening Type, 2025-2032
  - 5.3.3.1. Stool-based Tests
    - 5.3.3.1.1. Fecal Immunochemical Test (FIT)
    - 5.3.3.1.2. Guaiac-based Fecal Occult Blood Test (gFOBT)
    - 5.3.3.1.3. Others
  - 5.3.3.2. Colonoscopy
  - 5.3.3.3. Flexible Sigmoidoscopy
  - 5.3.3.4. Capsule Endoscopy
  - 5.3.3.5. Others
- 5.3.4. Market Attractiveness Analysis: Screening Type
5.4. Global Colon Screening Market Outlook: Product Type
- 5.4.1. Introduction / Key Findings
- 5.4.2. Historical Market Size (US$ Bn) Analysis, By Product Type, 2019 - 2024
- 5.4.3. Current Market Size (US$ Bn) Analysis and Forecast, By Product Type, 2025-2032
  - 5.4.3.1. Endoscopes
  - 5.4.3.2. CT Scanners
  - 5.4.3.3. Capsule Endoscopes
  - 5.4.3.4. Test Kits & Reagents
  - 5.4.3.5. Others
- 5.4.4. Market Attractiveness Analysis: Product Type
5.5. Global Colon Screening Market Outlook: End-user
- 5.5.1. Introduction / Key Findings
- 5.5.2. Historical Market Size (US$ Bn) Analysis, By End-user, 2019 - 2024
- 5.5.3. Current Market Size (US$ Bn) Analysis and Forecast, By End-user, 2025-2032
  - 5.5.3.1. Hospitals
  - 5.5.3.2. Diagnostic & Imaging Centers
  - 5.5.3.3. Research & Academic Institutions
  - 5.5.3.4. Others
- 5.5.4. Market Attractiveness Analysis: End-user

6. Global Colon Screening Market Outlook: Region

6.1. Key Highlights
6.2. Historical Market Size (US$ Bn) and Volume (Units) Analysis, By Region, 2019 - 2024
6.3. Current Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By Region, 2025-2032
- 6.3.1. North America
- 6.3.2. Europe
- 6.3.3. East Asia
- 6.3.4. South Asia and Oceania
- 6.3.5. Latin America
- 6.3.6. Middle East & Africa
6.4. Market Attractiveness Analysis: Region

7. North America Colon Screening Market Outlook

7.1. Key Highlights
7.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019 - 2024
- 7.2.1. By Country
- 7.2.2. By Screening Type
- 7.2.3. By Product Type
- 7.2.4. By End-user
- 7.2.5. By Application
7.3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2025-2032
- 7.3.1. U.S.
- 7.3.2. Canada
7.4. Current Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By Screening Type, 2025-2032
- 7.4.1. Stool-based Tests
  - 7.4.1.1. Fecal Immunochemical Test (FIT)
  - 7.4.1.2. Guaiac-based Fecal Occult Blood Test (gFOBT)
  - 7.4.1.3. Others
- 7.4.2. Colonoscopy
- 7.4.3. Flexible Sigmoidoscopy
- 7.4.4. Capsule Endoscopy
- 7.4.5. Others
7.5. Current Market Size (US$ Bn) Analysis and Forecast, By Product Type, 2025-2032
- 7.5.1. Endoscopes
- 7.5.2. CT Scanners
- 7.5.3. Capsule Endoscopes
- 7.5.4. Test Kits & Reagents
- 7.5.5. Others
7.6. Current Market Size (US$ Bn) Analysis and Forecast, By End-user, 2025-2032
- 7.6.1. Hospitals
- 7.6.2. Diagnostic & Imaging Centers
- 7.6.3. Research & Academic Institutions
- 7.6.4. Others
7.7. Market Attractiveness Analysis

8. Europe Colon Screening Market Outlook

8.1. Key Highlights
8.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019 - 2024
- 8.2.1. By Country
- 8.2.2. By Screening Type
- 8.2.3. By Product Type
- 8.2.4. By End-user
- 8.2.5. By Application
8.3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2025-2032
- 8.3.1. Germany
- 8.3.2. France
- 8.3.3. U.K.
- 8.3.4. Italy
- 8.3.5. Spain
- 8.3.6. Russia
- 8.3.7. Turkey
- 8.3.8. Rest of Europe
8.4. Current Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By Screening Type, 2025-2032
- 8.4.1. Stool-based Tests
  - 8.4.1.1. Fecal Immunochemical Test (FIT)
  - 8.4.1.2. Guaiac-based Fecal Occult Blood Test (gFOBT)
  - 8.4.1.3. Others
- 8.4.2. Colonoscopy
- 8.4.3. Flexible Sigmoidoscopy
- 8.4.4. Capsule Endoscopy
- 8.4.5. Others
8.5. Current Market Size (US$ Bn) Analysis and Forecast, By Product Type, 2025-2032
- 8.5.1. Endoscopes
- 8.5.2. CT Scanners
- 8.5.3. Capsule Endoscopes
- 8.5.4. Test Kits & Reagents
- 8.5.5. Others
8.6. Current Market Size (US$ Bn) Analysis and Forecast, By End-user, 2025-2032
- 8.6.1. Hospitals
- 8.6.2. Diagnostic & Imaging Centers
- 8.6.3. Research & Academic Institutions
- 8.6.4. Others
8.7. Market Attractiveness Analysis

9. East Asia Colon Screening Market Outlook

9.1. Key Highlights
9.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019 - 2024
- 9.2.1. By Country
- 9.2.2. By Screening Type
- 9.2.3. By Product Type
- 9.2.4. By End-user
- 9.2.5. By Application
9.3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2025-2032
- 9.3.1. China
- 9.3.2. Japan
- 9.3.3. South Korea
9.4. Current Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By Screening Type, 2025-2032
- 9.4.1. Stool-based Tests
  - 9.4.1.1. Fecal Immunochemical Test (FIT)
  - 9.4.1.2. Guaiac-based Fecal Occult Blood Test (gFOBT)
  - 9.4.1.3. Others
- 9.4.2. Colonoscopy
- 9.4.3. Flexible Sigmoidoscopy
- 9.4.4. Capsule Endoscopy
- 9.4.5. Others
9.5. Current Market Size (US$ Bn) Analysis and Forecast, By Product Type, 2025-2032
- 9.5.1. Endoscopes
- 9.5.2. CT Scanners
- 9.5.3. Capsule Endoscopes
- 9.5.4. Test Kits & Reagents
- 9.5.5. Others
9.6. Current Market Size (US$ Bn) Analysis and Forecast, By End-user, 2025-2032
- 9.6.1. Hospitals
- 9.6.2. Diagnostic & Imaging Centers
- 9.6.3. Research & Academic Institutions
- 9.6.4. Others
9.7. Market Attractiveness Analysis

10. South Asia & Oceania Colon Screening Market Outlook

10.1. Key Highlights
10.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019 - 2024
- 10.2.1. By Country
- 10.2.2. By Screening Type
- 10.2.3. By Product Type
- 10.2.4. By End-user
- 10.2.5. By Application
10.3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2025-2032
- 10.3.1. India
- 10.3.2. Southeast Asia
- 10.3.3. ANZ
- 10.3.4. Rest of South Asia & Oceania
10.4. Current Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By Screening Type, 2025-2032
- 10.4.1. Stool-based Tests
  - 10.4.1.1. Fecal Immunochemical Test (FIT)
  - 10.4.1.2. Guaiac-based Fecal Occult Blood Test (gFOBT)
  - 10.4.1.3. Others
- 10.4.2. Colonoscopy
- 10.4.3. Flexible Sigmoidoscopy
- 10.4.4. Capsule Endoscopy
- 10.4.5. Others
10.5. Current Market Size (US$ Bn) Analysis and Forecast, By Product Type, 2025-2032
- 10.5.1. Endoscopes
- 10.5.2. CT Scanners
- 10.5.3. Capsule Endoscopes
- 10.5.4. Test Kits & Reagents
- 10.5.5. Others
10.6. Current Market Size (US$ Bn) Analysis and Forecast, By End-user, 2025-2032
- 10.6.1. Hospitals
- 10.6.2. Diagnostic & Imaging Centers
- 10.6.3. Research & Academic Institutions
- 10.6.4. Others
10.7. Market Attractiveness Analysis

11. Latin America Colon Screening Market Outlook

11.1. Key Highlights
11.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019 - 2024
- 11.2.1. By Country
- 11.2.2. By Screening Type
- 11.2.3. By Product Type
- 11.2.4. By End-user
- 11.2.5. By Application
11.3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2025-2032
- 11.3.1. Brazil
- 11.3.2. Mexico
- 11.3.3. Rest of Latin America
11.4. Current Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By Screening Type, 2025-2032
- 11.4.1. Stool-based Tests
  - 11.4.1.1. Fecal Immunochemical Test (FIT)
  - 11.4.1.2. Guaiac-based Fecal Occult Blood Test (gFOBT)
  - 11.4.1.3. Others
- 11.4.2. Colonoscopy
- 11.4.3. Flexible Sigmoidoscopy
- 11.4.4. Capsule Endoscopy
- 11.4.5. Others
11.5. Current Market Size (US$ Bn) Analysis and Forecast, By Product Type, 2025-2032
- 11.5.1. Endoscopes
- 11.5.2. CT Scanners
- 11.5.3. Capsule Endoscopes
- 11.5.4. Test Kits & Reagents
- 11.5.5. Others
11.6. Current Market Size (US$ Bn) Analysis and Forecast, By End-user, 2025-2032
- 11.6.1. Hospitals
- 11.6.2. Diagnostic & Imaging Centers
- 11.6.3. Research & Academic Institutions
- 11.6.4. Others
11.7. Market Attractiveness Analysis

12. Middle East & Africa Colon Screening Market Outlook

12.1. Key Highlights
12.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019 - 2024
- 12.2.1. By Country
- 12.2.2. By Screening Type
- 12.2.3. By Product Type
- 12.2.4. By End-user
- 12.2.5. By Application
12.3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2025-2032
- 12.3.1. GCC Countries
- 12.3.2. Egypt
- 12.3.3. South Africa
- 12.3.4. Northern Africa
- 12.3.5. Rest of Middle East & Africa
12.4. Current Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By Screening Type, 2025-2032
- 12.4.1. Stool-based Tests
  - 12.4.1.1. Fecal Immunochemical Test (FIT)
  - 12.4.1.2. Guaiac-based Fecal Occult Blood Test (gFOBT)
  - 12.4.1.3. Others
- 12.4.2. Colonoscopy
- 12.4.3. Flexible Sigmoidoscopy
- 12.4.4. Capsule Endoscopy
- 12.4.5. Others
12.5. Current Market Size (US$ Bn) Analysis and Forecast, By Product Type, 2025-2032
- 12.5.1. Endoscopes
- 12.5.2. CT Scanners
- 12.5.3. Capsule Endoscopes
- 12.5.4. Test Kits & Reagents
- 12.5.5. Others
12.6. Current Market Size (US$ Bn) Analysis and Forecast, By End-user, 2025-2032
- 12.6.1. Hospitals
- 12.6.2. Diagnostic & Imaging Centers
- 12.6.3. Research & Academic Institutions
- 12.6.4. Others
12.7. Market Attractiveness Analysis

13. Competition Landscape

13.1. Market Share Analysis, 2024
13.2. Market Structure
- 13.2.1. Competition Intensity Mapping By Market
- 13.2.2. Competition Dashboard
13.3. Company Profiles (Details - Overview, Financials, Strategy, Recent Developments)
- 13.3.1. Olympus Corporation
  - 13.3.1.1. Overview
  - 13.3.1.2. Segments and Deployments
  - 13.3.1.3. Key Financials
  - 13.3.1.4. Market Developments
  - 13.3.1.5. Market Strategy
- 13.3.2. PENTAX Medical (Hoya Corporation)
- 13.3.3. FUJIFILM Holdings Corporation
- 13.3.4. Medtronic
- 13.3.5. Ambu A/S
- 13.3.6. Baxter (Hillrom & Welch Allyn)
- 13.3.7. EndoFresh
- 13.3.8. Bracco S.p.A.
- 13.3.9. Varay Laborix
- 13.3.10. QuidelOrtho Corporation
- 13.3.11. Novigenix SA
- 13.3.12. Guardant Health, Inc.
- 13.3.13. Mainz Biomed N.V.
- 13.3.14. Eiken Chemical Co., Ltd.

14. Appendix

14.1. Research Methodology
14.2. Research Assumptions
14.3. Acronyms and Abbreviations